학술논문
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
Document Type
Article
Author
Source
In: International Journal of Clinical Oncology . (International Journal of Clinical Oncology, December 2022, 27(12):1881-1890)
Subject
Language
English
ISSN
14377772
13419625
13419625